Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Persistent high antibody titres against Coxiella burnetiiafter acute Q fever not explained by continued exposure to the source of infection: a case-control study

Authors: Rana Jajou, Cornelia Christina Henrica Wielders, Monique Leclercq, Jeroen van Leuken, Shahan Shamelian, Nicole Renders, Wim van der Hoek, Peter Schneeberger

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

From 2007 to 2010, (the southern part of) the Netherlands experienced a large Q fever epidemic, with more than 4,000 reported symptomatic cases. Approximately 1 - 5% of the acute Q fever patients develop chronic Q fever. A high IgG antibody titre against phase I of Coxiella burnetii during follow-up is considered a marker of chronic Q fever. However, there is uncertainty about the significance and cause of persistence of high IgG phase I antibody titres in patients that do not have any additional manifestations of chronic Q fever. We studied whether continued or repeated exposure to the source of infection could explain elevated IgG phase I antibody levels.

Methods

A case-control study was performed to analyze predictors for possible chronic Q fever. Possible chronic Q fever cases (n = 53) are patients with phase I IgG antibody titre ≥1:1,024 at any point in the 9 - 18 months after acute Q fever diagnosis, with a negative PCR test result for C. burnetii DNA and without other disease manifestations. Controls (n = 110) are acute Q fever patients that did not develop chronic Q fever, and who consistently had phase I IgG antibody titre <1:1,024 during the 9 - 18 months follow-up. Binary logistic regression was performed to analyze the effect of living close to an infected farm on the high antibody titres. A longitudinal analysis described the serological profiles of cases and controls.

Results

Proximity to infected farms and contact with animal placental material were not associated with an increased risk for possible chronic Q fever. Possible chronic Q fever patients have high IgG phase II as well as IgG phase I antibody titres, even after 48 months of follow-up.

Conclusion

We were unable to explain the cause of persistent high IgG phase I titres among possible chronic Q fever patients by being continuously exposed to the source of infection.
Appendix
Available only for authorised users
Literature
2.
go back to reference Tissot-Dupont H, Vaillant V, Rey S, Raoult D: Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007, 44 (2): 232-237. 10.1086/510389.CrossRefPubMed Tissot-Dupont H, Vaillant V, Rey S, Raoult D: Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis. 2007, 44 (2): 232-237. 10.1086/510389.CrossRefPubMed
3.
go back to reference Wegdam-Blans MCA, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren MEE, Notermans DW, Renders NHM, Bijlmer HA, Lestrade PJ, Koopmans MPG, Nabuurs-Franssen MH, Oosterheert JJ: Chronic Q fever: Review of the literature and a proposal of new diagnostic criteria. J Infect. 2012, 64 (3): 47-59. 10.1016/j.jinf.2011.12.014.CrossRef Wegdam-Blans MCA, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren MEE, Notermans DW, Renders NHM, Bijlmer HA, Lestrade PJ, Koopmans MPG, Nabuurs-Franssen MH, Oosterheert JJ: Chronic Q fever: Review of the literature and a proposal of new diagnostic criteria. J Infect. 2012, 64 (3): 47-59. 10.1016/j.jinf.2011.12.014.CrossRef
4.
go back to reference Kampschreur LM, Dekker S, Hagenaars CJP, Lestrade PJ, Renders NHM, de Jager-Leclercq MGL, Hermans MHA, Groot CAR, Groenwold RHH, Hoepelman AIM, Wever PC, Oosterheert JJ: Identification of Risk Factors for Chronic Q Fever, the Netherlands. Emerg Infecti Dis. 2012, 18 (4): 563-567.CrossRef Kampschreur LM, Dekker S, Hagenaars CJP, Lestrade PJ, Renders NHM, de Jager-Leclercq MGL, Hermans MHA, Groot CAR, Groenwold RHH, Hoepelman AIM, Wever PC, Oosterheert JJ: Identification of Risk Factors for Chronic Q Fever, the Netherlands. Emerg Infecti Dis. 2012, 18 (4): 563-567.CrossRef
5.
go back to reference Limonard GJM, Nabuurs-Franssen MH, Weers-Pothoff H, Wijkmans C, Besselink R, Horrevorts AM, Schneeberger PM, Groot CAR: One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection. 2010, 38 (6): 471-477. 10.1007/s15010-010-0052-x.CrossRefPubMedPubMedCentral Limonard GJM, Nabuurs-Franssen MH, Weers-Pothoff H, Wijkmans C, Besselink R, Horrevorts AM, Schneeberger PM, Groot CAR: One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings. Infection. 2010, 38 (6): 471-477. 10.1007/s15010-010-0052-x.CrossRefPubMedPubMedCentral
6.
go back to reference Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367 (9511): 679-688. 10.1016/S0140-6736(06)68266-4.CrossRefPubMed Parker NR, Barralet JH, Bell AM: Q fever. Lancet. 2006, 367 (9511): 679-688. 10.1016/S0140-6736(06)68266-4.CrossRefPubMed
7.
go back to reference Dupont HT, Thirion X, Raoulti D: Q Fever Serology: Cutoff Determination for Microimmunofluorescence. Clin Diagn Lab Immunol. 1994, 1: 189-196.PubMedPubMedCentral Dupont HT, Thirion X, Raoulti D: Q Fever Serology: Cutoff Determination for Microimmunofluorescence. Clin Diagn Lab Immunol. 1994, 1: 189-196.PubMedPubMedCentral
8.
go back to reference Anderson A, Bijlmer H, Fournier PE, Graves S, Hartzell J, Kersh GJ, Limonard G, Marrie TJ, Massung RF, McQuiston JH, Nicholson WL, Paddock CD, Sexton DJ: Diagnosis and management of Q fever - United States, 2013: recommendations from CDC and the Q fever working group. Morb Mortal Wkly Rep. 2013, 62 (3): 1-30. Anderson A, Bijlmer H, Fournier PE, Graves S, Hartzell J, Kersh GJ, Limonard G, Marrie TJ, Massung RF, McQuiston JH, Nicholson WL, Paddock CD, Sexton DJ: Diagnosis and management of Q fever - United States, 2013: recommendations from CDC and the Q fever working group. Morb Mortal Wkly Rep. 2013, 62 (3): 1-30.
9.
go back to reference de Bruin A, van der Plaats RQJ, de Heer L, Paauwe R, Schimmer B, Vellema P, van Rotterdam BJ, van Duynhoven YTHP: Detection of Coxiella burnetii DNA on small-ruminant farms during a Q fever outbreak in the Netherlands. Appl Environ Microbiol. 2012, 78 (6): 1652-1657. 10.1128/AEM.07323-11.CrossRefPubMedPubMedCentral de Bruin A, van der Plaats RQJ, de Heer L, Paauwe R, Schimmer B, Vellema P, van Rotterdam BJ, van Duynhoven YTHP: Detection of Coxiella burnetii DNA on small-ruminant farms during a Q fever outbreak in the Netherlands. Appl Environ Microbiol. 2012, 78 (6): 1652-1657. 10.1128/AEM.07323-11.CrossRefPubMedPubMedCentral
10.
go back to reference Dorko E, Rimárová K, Pilipčinec E: Influence of the environment and occupational exposure on the occurrence of Q fever. Cent Eur J Public Health. 2012, 20 (3): 208-214.PubMed Dorko E, Rimárová K, Pilipčinec E: Influence of the environment and occupational exposure on the occurrence of Q fever. Cent Eur J Public Health. 2012, 20 (3): 208-214.PubMed
11.
go back to reference Donaghy M, Prempeh H, Macdonald N: Outbreak of Q fever in workers at a meat processing plant in Scotland, July 2006. Eurosurveillance. 2006, 11 (34): ppi=3031- Donaghy M, Prempeh H, Macdonald N: Outbreak of Q fever in workers at a meat processing plant in Scotland, July 2006. Eurosurveillance. 2006, 11 (34): ppi=3031-
12.
go back to reference Abe T, Yamaki K, Hayakawa T, Ito Y, Kume H, Komiya T, Ishihara K, Hirai K: A seroepidemiological study of the risks of Q fever infection in Japanese veterinarians. Eur J Epidemiol. 2001, 17 (11): 1029-1032. 10.1023/A:1020018907452.CrossRefPubMed Abe T, Yamaki K, Hayakawa T, Ito Y, Kume H, Komiya T, Ishihara K, Hirai K: A seroepidemiological study of the risks of Q fever infection in Japanese veterinarians. Eur J Epidemiol. 2001, 17 (11): 1029-1032. 10.1023/A:1020018907452.CrossRefPubMed
13.
go back to reference Marrie TJ, Durant H, Williams JC, Mintz E, Waag DM: Exposure to parturient cats: a risk factor for acquisition of Q fever in Maritime Canada. J Infect Dis. 1988, 158 (1): 101-108. 10.1093/infdis/158.1.101.CrossRefPubMed Marrie TJ, Durant H, Williams JC, Mintz E, Waag DM: Exposure to parturient cats: a risk factor for acquisition of Q fever in Maritime Canada. J Infect Dis. 1988, 158 (1): 101-108. 10.1093/infdis/158.1.101.CrossRefPubMed
14.
go back to reference Psaroulaki A, Hadjichristodoulou C, Loukaides F, Soteriades E, Konstantinidis A, Papastergiou P, Ioannidou MC, Tselentis Y: Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system. Eur J Microbiol Infect Dis. 2006, 25 (9): 576-586. 10.1007/s10096-006-0170-7.CrossRef Psaroulaki A, Hadjichristodoulou C, Loukaides F, Soteriades E, Konstantinidis A, Papastergiou P, Ioannidou MC, Tselentis Y: Epidemiological study of Q fever in humans, ruminant animals, and ticks in Cyprus using a geographical information system. Eur J Microbiol Infect Dis. 2006, 25 (9): 576-586. 10.1007/s10096-006-0170-7.CrossRef
15.
go back to reference van den Brom R, Schimmer B, Schneeberger PM, Swart WA, van der Hoek W, Vellema P: Seroepidemiological survey for Coxiella burnetii antibodies and associated risk factors in Dutch livestock veterinarians. Plos one. 2013, 8 (1): e54021-10.1371/journal.pone.0054021.CrossRefPubMedPubMedCentral van den Brom R, Schimmer B, Schneeberger PM, Swart WA, van der Hoek W, Vellema P: Seroepidemiological survey for Coxiella burnetii antibodies and associated risk factors in Dutch livestock veterinarians. Plos one. 2013, 8 (1): e54021-10.1371/journal.pone.0054021.CrossRefPubMedPubMedCentral
16.
go back to reference Georgiev M, Afonso A, Neubauer H, Needham H, Thiéry R, Rodolakis A, Roest HJ, Stärk KD, Stegeman JA, Vellema P, van der Hoek W, More SJ:: Q fever in humans and farm animals in four European countries, 1982 to 2010. Eurosurveillance. 2013, 18 (8): ppi=20407- Georgiev M, Afonso A, Neubauer H, Needham H, Thiéry R, Rodolakis A, Roest HJ, Stärk KD, Stegeman JA, Vellema P, van der Hoek W, More SJ:: Q fever in humans and farm animals in four European countries, 1982 to 2010. Eurosurveillance. 2013, 18 (8): ppi=20407-
18.
go back to reference Honarmand H: Q fever: an old but poorly understood disease. Interdiscip Perspect Infect Dis. 2012, 2012: 13132- Honarmand H: Q fever: an old but poorly understood disease. Interdiscip Perspect Infect Dis. 2012, 2012: 13132-
19.
go back to reference Schimmer B, Lenferink A, Schneeberger P, Aangenend H, Vellemal P, Hautvast J, van Duynhoven Y: Seroprevalence and Risk Factors for Coxiella burnetii (Q Fever) Seropositivity in Dairy Goat Farmers' households in the Netherlands, 2009-2010. Plos One. 2012, 7 (7): e42364-10.1371/journal.pone.0042364.CrossRefPubMedPubMedCentral Schimmer B, Lenferink A, Schneeberger P, Aangenend H, Vellemal P, Hautvast J, van Duynhoven Y: Seroprevalence and Risk Factors for Coxiella burnetii (Q Fever) Seropositivity in Dairy Goat Farmers' households in the Netherlands, 2009-2010. Plos One. 2012, 7 (7): e42364-10.1371/journal.pone.0042364.CrossRefPubMedPubMedCentral
20.
go back to reference Porten K, Rissland J, Tigges A, Broll S, Hopp W, Lunemann M, van Treeck U, Kimmig P, O Borckmann S, Wager-Wiening C, Hellenbrand W, Buchholz U: A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany. BMC Infect Dis. 2006, 6: 147-10.1186/1471-2334-6-147.CrossRefPubMedPubMedCentral Porten K, Rissland J, Tigges A, Broll S, Hopp W, Lunemann M, van Treeck U, Kimmig P, O Borckmann S, Wager-Wiening C, Hellenbrand W, Buchholz U: A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany. BMC Infect Dis. 2006, 6: 147-10.1186/1471-2334-6-147.CrossRefPubMedPubMedCentral
21.
go back to reference Dijkstra F, van der Hoek W, Wijers N, Schimmer B, Rietveld A, Wijkmans CJ, Vellema P, Schneeberger PM: The 2007-2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol. 2012, 64 (1): 3-12. 10.1111/j.1574-695X.2011.00876.x.CrossRefPubMed Dijkstra F, van der Hoek W, Wijers N, Schimmer B, Rietveld A, Wijkmans CJ, Vellema P, Schneeberger PM: The 2007-2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol. 2012, 64 (1): 3-12. 10.1111/j.1574-695X.2011.00876.x.CrossRefPubMed
22.
go back to reference van der Hoek W, Morroy G, Renders NH, Wever PC, Hermans MH, Leenders AC, Schneeberger PM: Epidemic Q fever in humans in the Netherlands. Adv Exp Med Biol. 2012, 984: 329-364. 10.1007/978-94-007-4315-1_17.CrossRefPubMed van der Hoek W, Morroy G, Renders NH, Wever PC, Hermans MH, Leenders AC, Schneeberger PM: Epidemic Q fever in humans in the Netherlands. Adv Exp Med Biol. 2012, 984: 329-364. 10.1007/978-94-007-4315-1_17.CrossRefPubMed
23.
go back to reference Schimmer B, ter Schegget R, Wegdam M, Züchner L, de Bruin A, Schneeberger PM, Veenstra T, Vellemal P, van der Hoek W: The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis. 2010, 10: 69-10.1186/1471-2334-10-69.CrossRefPubMedPubMedCentral Schimmer B, ter Schegget R, Wegdam M, Züchner L, de Bruin A, Schneeberger PM, Veenstra T, Vellemal P, van der Hoek W: The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis. 2010, 10: 69-10.1186/1471-2334-10-69.CrossRefPubMedPubMedCentral
24.
go back to reference van der Hoek W, Hunink J, Vellema P, Droogers P: Q fever in The Netherlands: the role of local environmental conditions. Int J Environ Health Res. 2011, 21 (6): 441-451. 10.1080/09603123.2011.574270.CrossRefPubMed van der Hoek W, Hunink J, Vellema P, Droogers P: Q fever in The Netherlands: the role of local environmental conditions. Int J Environ Health Res. 2011, 21 (6): 441-451. 10.1080/09603123.2011.574270.CrossRefPubMed
26.
go back to reference Reedijk M, van leuken JPG, van der Hoek W: Particulate matter strongly associated with human Q fever in the Netherlands: an ecological study. Epidemiol Infect. 2013, 141 (12): 2623-2633. 10.1017/S0950268813000460.CrossRefPubMed Reedijk M, van leuken JPG, van der Hoek W: Particulate matter strongly associated with human Q fever in the Netherlands: an ecological study. Epidemiol Infect. 2013, 141 (12): 2623-2633. 10.1017/S0950268813000460.CrossRefPubMed
27.
go back to reference Kampschreur LM, Hagenaars JCJP, Wielders CCH, Elsman P, Lestrade PJ, Koning OHJ, Oosterheert JJ, Renders NHM, Wever PC: Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect. 2013, 141 (4): 847-851. 10.1017/S0950268812001203.CrossRefPubMed Kampschreur LM, Hagenaars JCJP, Wielders CCH, Elsman P, Lestrade PJ, Koning OHJ, Oosterheert JJ, Renders NHM, Wever PC: Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect. 2013, 141 (4): 847-851. 10.1017/S0950268812001203.CrossRefPubMed
28.
go back to reference van der Hoek W, Schneeberger PM, Oomen T, Wegdam-Blans MC, Dijkstra F, Notermans DW, Bijlmer HA, Groeneveld K, Wijkmans CJ, Rietveld A, Kampschreur LM, van Duynhoven Y: Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in the Netherlands: from acute to chronic infection. Eurosurveillance. 2012, 17 (3): 20059-PubMed van der Hoek W, Schneeberger PM, Oomen T, Wegdam-Blans MC, Dijkstra F, Notermans DW, Bijlmer HA, Groeneveld K, Wijkmans CJ, Rietveld A, Kampschreur LM, van Duynhoven Y: Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in the Netherlands: from acute to chronic infection. Eurosurveillance. 2012, 17 (3): 20059-PubMed
29.
go back to reference Hogerwerf L, van den Brom R, Roest HIJ, Bouma A, Vellema P, Pieterse M, Dercksen D, Nielen M: Reduction of Coxiella burnetii Prevalence by Vaccination of Goats and Sheep, the Netherlands. Emerg Infect Diseases. 2011, 17 (3): 379-386. 10.3201/eid1703.101157.CrossRef Hogerwerf L, van den Brom R, Roest HIJ, Bouma A, Vellema P, Pieterse M, Dercksen D, Nielen M: Reduction of Coxiella burnetii Prevalence by Vaccination of Goats and Sheep, the Netherlands. Emerg Infect Diseases. 2011, 17 (3): 379-386. 10.3201/eid1703.101157.CrossRef
30.
go back to reference Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, Hoepelman AI, van Kasteren ME, Buijs J, Renders NH, Nabuurs-Franssen MH, Oosterheert JJ, Wever PC: Chronic q Fever in the Netherlands 5 years after the start of the q Fever epidemic: results from the dutch chronic q Fever database. J Clin Microbiol. 2014, 52 (5): 1637-1643. 10.1128/JCM.03221-13.CrossRefPubMedPubMedCentral Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, Hoepelman AI, van Kasteren ME, Buijs J, Renders NH, Nabuurs-Franssen MH, Oosterheert JJ, Wever PC: Chronic q Fever in the Netherlands 5 years after the start of the q Fever epidemic: results from the dutch chronic q Fever database. J Clin Microbiol. 2014, 52 (5): 1637-1643. 10.1128/JCM.03221-13.CrossRefPubMedPubMedCentral
31.
go back to reference Veenstra T, Snijders BE, Schimmer B, Rietveld A, van Dam S, Schneeberger PM, Dijkstra F, van der Sande MA, van der Hoek W: Risk Factors for Q Fever in the Netherlands. WebmedCentral Infect Dis. 2011, 2: 1-10. Veenstra T, Snijders BE, Schimmer B, Rietveld A, van Dam S, Schneeberger PM, Dijkstra F, van der Sande MA, van der Hoek W: Risk Factors for Q Fever in the Netherlands. WebmedCentral Infect Dis. 2011, 2: 1-10.
32.
go back to reference Thomas DRH, Treweek L, Salmon RL, Kench SM, Coleman TJ, Meadows D, Morgan-Capner P, Caul EO: The risk of acquiring Q fever on farms: a seroepidemiological study. Occup Environ Med. 1995, 52 (10): 644-647. 10.1136/oem.52.10.644.CrossRefPubMedPubMedCentral Thomas DRH, Treweek L, Salmon RL, Kench SM, Coleman TJ, Meadows D, Morgan-Capner P, Caul EO: The risk of acquiring Q fever on farms: a seroepidemiological study. Occup Environ Med. 1995, 52 (10): 644-647. 10.1136/oem.52.10.644.CrossRefPubMedPubMedCentral
33.
go back to reference Teunis PF, Schimmer B, Notermans DW, Leenders AC, Wever PC, Kretzschmar ME, Schneeberger PM: Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol Infect. 2013, 141 (1): 62-73. 10.1017/S0950268812000404.CrossRefPubMed Teunis PF, Schimmer B, Notermans DW, Leenders AC, Wever PC, Kretzschmar ME, Schneeberger PM: Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol Infect. 2013, 141 (1): 62-73. 10.1017/S0950268812000404.CrossRefPubMed
34.
go back to reference Wattiau P, Boldisova E, Toman R, Van Esbroeck M, Quoilin S, Hammadi S, Tissot-Dupont H, Raoult D, Henkinbrant JM, Van Hessche M, Fretin D: Q fever in Woolsorters. Belgium Emerg Infect Dis. 2011, 17 (12): 2368-2369.PubMed Wattiau P, Boldisova E, Toman R, Van Esbroeck M, Quoilin S, Hammadi S, Tissot-Dupont H, Raoult D, Henkinbrant JM, Van Hessche M, Fretin D: Q fever in Woolsorters. Belgium Emerg Infect Dis. 2011, 17 (12): 2368-2369.PubMed
Metadata
Title
Persistent high antibody titres against Coxiella burnetiiafter acute Q fever not explained by continued exposure to the source of infection: a case-control study
Authors
Rana Jajou
Cornelia Christina Henrica Wielders
Monique Leclercq
Jeroen van Leuken
Shahan Shamelian
Nicole Renders
Wim van der Hoek
Peter Schneeberger
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0629-6

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.